CU20160003A7 - Pirazololpiridinaminas sustituidas - Google Patents
Pirazololpiridinaminas sustituidasInfo
- Publication number
- CU20160003A7 CU20160003A7 CUP2016000003A CU20160003A CU20160003A7 CU 20160003 A7 CU20160003 A7 CU 20160003A7 CU P2016000003 A CUP2016000003 A CU P2016000003A CU 20160003 A CU20160003 A CU 20160003A CU 20160003 A7 CU20160003 A7 CU 20160003A7
- Authority
- CU
- Cuba
- Prior art keywords
- compounds
- pirazololpiridinaminas
- replaced
- preparing
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13175526 | 2013-07-08 | ||
| EP13194902 | 2013-11-28 | ||
| EP13195131 | 2013-11-29 | ||
| PCT/EP2014/064347 WO2015004024A1 (en) | 2013-07-08 | 2014-07-04 | Substituted pyrazolo-pyridinamines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20160003A7 true CU20160003A7 (es) | 2017-02-02 |
Family
ID=51162789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CUP2016000003A CU20160003A7 (es) | 2013-07-08 | 2016-01-08 | Pirazololpiridinaminas sustituidas |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20160159789A1 (ru) |
| EP (1) | EP3019505A1 (ru) |
| JP (1) | JP2016527216A (ru) |
| KR (1) | KR20160030239A (ru) |
| CN (1) | CN105531279A (ru) |
| AP (1) | AP2016009025A0 (ru) |
| AU (1) | AU2014289415A1 (ru) |
| CA (1) | CA2917380A1 (ru) |
| CL (1) | CL2016000038A1 (ru) |
| CR (1) | CR20160016A (ru) |
| CU (1) | CU20160003A7 (ru) |
| DO (1) | DOP2016000007A (ru) |
| EA (1) | EA201690183A1 (ru) |
| HK (1) | HK1223362A1 (ru) |
| IL (1) | IL243273A0 (ru) |
| MX (1) | MX2016000163A (ru) |
| NI (1) | NI201600006A (ru) |
| PE (1) | PE20160125A1 (ru) |
| PH (1) | PH12016500054A1 (ru) |
| SG (1) | SG11201510391VA (ru) |
| TN (1) | TN2016000005A1 (ru) |
| UY (1) | UY35651A (ru) |
| WO (1) | WO2015004024A1 (ru) |
| ZA (1) | ZA201600275B (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201605867A (zh) * | 2013-11-20 | 2016-02-16 | 拜耳製藥公司 | 噻吩并嘧啶 |
| KR20180004740A (ko) * | 2015-04-20 | 2018-01-12 | 이펙터 테라퓨틱스, 인크. | 암 및 감염 치료에 사용하기 위한 면역 체크포인트 조절 인자의 억제제 |
| GB201520500D0 (en) * | 2015-11-20 | 2016-01-06 | Medical Res Council Technology | Compounds |
| US9630968B1 (en) | 2015-12-23 | 2017-04-25 | Arqule, Inc. | Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof |
| TW201811795A (zh) | 2016-08-24 | 2018-04-01 | 美商亞闊股份有限公司 | 胺基－吡咯并嘧啶酮化合物及其用途 |
| CA3050599A1 (en) * | 2017-01-20 | 2018-07-26 | Bayer Pharma Aktiengesellschaft | Substituted imidazopyridinpyrimidines |
| WO2021005183A1 (en) | 2019-07-10 | 2021-01-14 | Fundació Hospital Universitari Vall D'hebron - Institut De Recerca | Inhibitor of map kinase interacting serine/threonine kinase 1 (mnk1) and map kinase interacting serine/threonine kinase 2 (mnk2), cancer therapy and therapeutic combinations |
| CN110483523B (zh) * | 2019-08-27 | 2022-11-22 | 药雅科技(上海)有限公司 | 一种吡唑并嘧啶衍生物表皮生长因子抑制剂及其制备方法与用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2280040T3 (es) * | 2003-07-24 | 2007-09-01 | Bayer Pharmaceuticals Corporation | Compuestos de tetrahidrobenzotienopirimidinamina sustituidos utiles para tratar trastornos hiperproliferativos. |
| WO2007076161A2 (en) * | 2005-12-27 | 2007-07-05 | Myriad Genetics, Inc | Compounds with therapeutic activity |
| EP1889847A1 (en) * | 2006-07-10 | 2008-02-20 | DeveloGen Aktiengesellschaft | Pyrrolopyrimidines for pharmaceutical compositions |
| PE20091623A1 (es) * | 2008-02-29 | 2009-11-19 | Array Biopharma Inc | DERIVADOS DE 1H-PIRAZOLO[3,4-b]PIRIDINA COMO INHIBIDORES DE RAF QUINASA |
| US20120157452A1 (en) * | 2009-08-28 | 2012-06-21 | Genentech, Inc. | 1h-pyrazolo[3,4-b] pyridine compounds for inhibiting raf kinase |
| TW201141483A (en) * | 2010-02-26 | 2011-12-01 | Boehringer Ingelheim Int | Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions |
| JP2015501793A (ja) * | 2011-11-10 | 2015-01-19 | オーエスアイ・ファーマシューティカルズ，エルエルシー | ジヒドロプテリジノン類 |
-
2014
- 2014-07-04 CN CN201480049419.4A patent/CN105531279A/zh active Pending
- 2014-07-04 PE PE2016000029A patent/PE20160125A1/es not_active Application Discontinuation
- 2014-07-04 JP JP2016524760A patent/JP2016527216A/ja active Pending
- 2014-07-04 AU AU2014289415A patent/AU2014289415A1/en not_active Abandoned
- 2014-07-04 CA CA2917380A patent/CA2917380A1/en not_active Abandoned
- 2014-07-04 SG SG11201510391VA patent/SG11201510391VA/en unknown
- 2014-07-04 KR KR1020167003079A patent/KR20160030239A/ko not_active Application Discontinuation
- 2014-07-04 AP AP2016009025A patent/AP2016009025A0/en unknown
- 2014-07-04 MX MX2016000163A patent/MX2016000163A/es unknown
- 2014-07-04 EA EA201690183A patent/EA201690183A1/ru unknown
- 2014-07-04 EP EP14736772.6A patent/EP3019505A1/en not_active Withdrawn
- 2014-07-04 US US14/903,423 patent/US20160159789A1/en not_active Abandoned
- 2014-07-04 WO PCT/EP2014/064347 patent/WO2015004024A1/en active Application Filing
- 2014-07-04 TN TN2016000005A patent/TN2016000005A1/en unknown
- 2014-07-08 UY UY35651A patent/UY35651A/es not_active Application Discontinuation
-
2015
- 2015-12-21 IL IL243273A patent/IL243273A0/en unknown
-
2016
- 2016-01-07 PH PH12016500054A patent/PH12016500054A1/en unknown
- 2016-01-08 CR CR20160016A patent/CR20160016A/es unknown
- 2016-01-08 NI NI201600006A patent/NI201600006A/es unknown
- 2016-01-08 CU CUP2016000003A patent/CU20160003A7/es unknown
- 2016-01-08 CL CL2016000038A patent/CL2016000038A1/es unknown
- 2016-01-08 DO DO2016000007A patent/DOP2016000007A/es unknown
- 2016-01-13 ZA ZA2016/00275A patent/ZA201600275B/en unknown
- 2016-10-05 HK HK16111573.4A patent/HK1223362A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TN2016000005A1 (en) | 2017-07-05 |
| MX2016000163A (es) | 2016-04-15 |
| KR20160030239A (ko) | 2016-03-16 |
| AU2014289415A1 (en) | 2016-01-21 |
| SG11201510391VA (en) | 2016-01-28 |
| EP3019505A1 (en) | 2016-05-18 |
| CR20160016A (es) | 2016-03-04 |
| JP2016527216A (ja) | 2016-09-08 |
| US20160159789A1 (en) | 2016-06-09 |
| HK1223362A1 (zh) | 2017-07-28 |
| UY35651A (es) | 2015-02-27 |
| WO2015004024A1 (en) | 2015-01-15 |
| CA2917380A1 (en) | 2015-01-15 |
| IL243273A0 (en) | 2016-02-29 |
| ZA201600275B (en) | 2019-04-24 |
| NI201600006A (es) | 2016-02-12 |
| AP2016009025A0 (en) | 2016-02-29 |
| CL2016000038A1 (es) | 2016-07-29 |
| PH12016500054A1 (en) | 2016-04-04 |
| CN105531279A (zh) | 2016-04-27 |
| EA201690183A1 (ru) | 2016-06-30 |
| DOP2016000007A (es) | 2016-02-15 |
| PE20160125A1 (es) | 2016-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT201700146A (es) | Compuestos de triazolopirimidina y usos de los mismos | |
| CU20160003A7 (es) | Pirazololpiridinaminas sustituidas | |
| CU24411B1 (es) | Compuesto derivado de benzamida sustituida con 1,3-tiazol-2-ilo útil para el tratamiento de trastornos neurogénicos | |
| CR20150078A (es) | Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn | |
| CR20210079A (es) | Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
| CO2017001884A2 (es) | Polimorfos de selinexor | |
| CR20150418A (es) | Compuestos de tetrahidropirrolotiazina | |
| EA201692219A1 (ru) | Способы получения противовирусных соединений | |
| EA201590321A1 (ru) | Дейтерированный барицитиниб | |
| DOP2015000201A (es) | Compuestos de azabencimidazol como inhibidores de pde4 isoenzimas para el tratamiento del snc y otros trastornos | |
| GT201500247A (es) | Imidazopiridazinas sustituidas | |
| CR20160227A (es) | Nuevo compuesto para el tratamiento de hipoglicemia severa | |
| ECSP16024798A (es) | Nuevo compuesto para el tratamiento de hipoglicemia severa | |
| ECSP16024805A (es) | Nuevo compuesto para el tratamiento de hipoglicemia severa | |
| AR101951A1 (es) | Síntesis de ent-progesterona e intermediarios de la misma | |
| EA201591449A1 (ru) | Способы получения противораковых композиций | |
| PH12015502703A1 (en) | Pharmaceutical compositions | |
| AR098134A1 (es) | Compuestos de urea | |
| UY34755A (es) | Agentes para el control de la glycaspis brimblecombei | |
| CL2016000498A1 (es) | Proceso para la producción de lactato. | |
| EA201690709A1 (ru) | Применение одипарцила в лечении мукополисахаридоза | |
| GT201500232A (es) | Compuestos de azabencimidazol como inhibidores de las isozimas pde4 para el tratamiento de cns y otros trastornos | |
| TR201314937A2 (tr) | Viral enfeksiyonların tedavisine yönelik bir kompozisyon. | |
| TR201314933A2 (tr) | Bakteriyel enfeksiyonların tedavisine yönelik bir kompozisyon. | |
| PL405775A1 (pl) | Nowy związek, zwłaszcza do stosowania jako pigment |